{"EPA_reg_num": "6836-136", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-18F", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1099}
{"EPA_reg_num": "6836-140", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-21F", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1100}
{"EPA_reg_num": "6836-77", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-18", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1102}
{"EPA_reg_num": "6836-381", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonzagard R-82G", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1103}
{"EPA_reg_num": "6836-139", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation R-82F", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1104}
{"EPA_reg_num": "6836-75", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation S-21", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1109}
{"EPA_reg_num": "6836-78", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation R-82", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Dilutable\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1110}
{"EPA_reg_num": "6836-442", "Risk_level": "Safer", "Active_ingredient": "[\"Hydrogen peroxide\"]", "Product_name": "DS6835", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 0.5, "Formulation_type": "[\"Ready-to-use\", \"Electrostatic Spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1092}
{"EPA_reg_num": "70627-56", "Risk_level": "Safer", "Active_ingredient": "[\"Hydrogen peroxide\"]", "Product_name": "Oxivir\u2122 Tb", "Company": "Diversey Inc", "Use_site": "[\"Healthcare\", \"Institutional\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Ready-to-use\", \"Electrostatic spray\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1076}
{"EPA_reg_num": "6836-152", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Lonza Formulation DC-103", "Company": "Arxada, LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 1.0, "Formulation_type": "[\"Ready-to-use\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1101}
{"EPA_reg_num": "1130-15", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\", \"Isopropanol (Isopropyl alcohol)\"]", "Product_name": "Weiman Germicidal Solution", "Company": "Weiman Products LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 2.0, "Formulation_type": "[\"Ready-to-use\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1225}
{"EPA_reg_num": "70144-1", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\", \"Isopropanol (Isopropyl alcohol)\"]", "Product_name": "Opti-Cide 3\u00ae", "Company": "Micro-Scientific LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 2.0, "Formulation_type": "[\"Ready-to-use\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1228}
{"EPA_reg_num": "70271-34", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "KIK Antibacterial Multipurpose Cleaner I", "Company": "KIK International LLC", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 10.0, "Formulation_type": "[\"Ready-to-use\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1292}
{"EPA_reg_num": "42182-13", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\", \"Ethanol (Ethyl alcohol)\"]", "Product_name": "Ironman Wipe", "Company": "Microban Products Company", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\", \"Food Contact Post-Rinse Required (FCR)\"]", "Contact_time": 0.1, "Formulation_type": "[\"Wipe\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1085}
{"EPA_reg_num": "67071-123", "Risk_level": "Increased Risk", "Active_ingredient": "[\"Quaternary ammonium\"]", "Product_name": "Acticide C&D 09 Wipes", "Company": "Thor Specialties Inc", "Use_site": "[\"Healthcare\", \"Institutional\", \"Residential\"]", "Surface_type": "[\"Hard Nonporous (HN)\"]", "Contact_time": 0.25, "Formulation_type": "[\"Wipe\"]", "Follow_directions_for_this_virus": "SARS-CoV-2", "Date_on_List_N": "2021-04-13", "Why_on_List_N": "Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim", "ID": 1540}